Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has assisted Peab in connection with a transaction with SkiStar
Mandate

Vinge has assisted Peab in connection with a transaction with SkiStar

May 28, 2021 Capital Markets and Public M&A Real Estate and Construction

Vinge has assisted Peab in connection with a transaction with Skistar, whereby Peab and SkiStar deepen the collaboration on management and development of properties in the Scandinavian mountains.

Through the transaction, three jointly owned lodges in the Swedish and Norwegian mountainside locations are transferred to the same group structure and in addition, the joint ventures will acquire three new lodges in Hemsedal in Norway, Lindvallen in Sälen and Hundfjället in Sälen (under construction) and development rights for around 60,000 GFA in Sälen, Vemdalen, Åre and Duved. In addition, in connection with the transaction, SkiStar is to sign new leases on both the newly acquired properties and the previously jointly owned properties.

Vinge’s team consisted of Charlotte Levin, Assur Badur, Kristoffer Larson and Joel Magnusson.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025